文献速递神经肿瘤神经重症

患者特异性钛增强磷酸钙植入物用于复杂颅骨缺损的修复与愈合

Patient-Specific Titanium-Reinforced Calcium Phosphate Implant for the Repair and Healing of Complex Cranial Defects.
PubMed 文献 · World Neurosurg · 2018-10-18

本研究回顾性分析50例患者52处颅骨缺损行钛增强磷酸钙(CaP-Ti)植入物颅骨修补的临床数据。患者既往自体骨或异质材料修补失败率为64%(32/50)。中位随访25个月,因早期术后感染或持续伤口裂开取出植入物率分别为1.9%(1/53)和3.8%(2/53)。组织学显示植入物部分均匀转化为血管化密质骨。作者认为CaP-Ti植入物似乎改善了既往高失败率患者的临床结局。

要点

  • CaP-Ti植入物用于复杂颅骨缺损,既往修补失败率64%(32/50)。
  • 中位随访25个月,感染取出率1.9%(1/53),伤口裂开取出率3.8%(2/53)。
  • 组织学显示植入物部分均匀转化为血管化密质骨。

核心结论

  • 作者认为CaP-Ti植入物似乎改善了既往颅骨修补高失败率患者的临床结局,其骨再生效应可能特别影响植入物的长期成功率。

研究设计与样本

  • 回顾性综述所有接受CaP-Ti颅骨修补术的患者,从医院计算机数据库和患者记录中收集全面临床数据,并对单个取出标本进行骨形成和骨整合分析。

主要发现

  • 50例患者52处颅骨缺损符合纳入标准,患者队列既往使用自体骨、异质材料或两者兼有的失败率为64%(32/50)。
  • 中位随访25个月,因早期术后感染取出植入物率为1.9%(1/53),因持续伤口裂开取出率为3.8%(2/53)。
  • 2例患者需局部伤口翻修手术但无需取出植入物,1例患者脑肿瘤复发并在植入后31个月取出植入物。
  • 组织学检查显示整个植入物部分但均匀地转化为血管化密质骨。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The reconstruction of complex cranial defects is challenging and is associated with a high complication rate. The development of a patient-specific, titanium-reinforced, calcium phosphate-based (CaP-Ti) implant with bone regenerative properties has previously been described in 2 case studies with the hypothesis that the implant may improve clinical outcome. OBJECTIVE: To identify whether the introduction of CaP-Ti implant has the potential to improve clinical outcome. METHODS: A retrospective review of all patients having undergone CaP-Ti cranioplasty was conducted. Comprehensive clinical data were collected from the hospital computer database and patient records. Bone formation and osseointegration were analyzed in a single retrieval specimen. RESULTS: Fifty patients, with 52 cranial defects, met the inclusion criteria. The patient cohort displayed a previous failure rate of 64% (32/50) with autologous bone, alloplastic materials, or both. At a median follow-up time of 25 months, the explantation rate due to either early postoperative infection or persistent wound dehiscence was 1.9% (1/53) or 3.8% (2/53), respectively. Surgical intervention with local wound revision was required in 2 patients without the need of implant removal. One patient had a brain tumor recurrence, and the implant was explanted 31 months after implantation. Histologic examination showed that the entire implant was partly yet evenly transformed into vascularized compact bone. CONCLUSION: In the present study the CaP-Ti implant appears to have improved the clinical outcomes in a cohort of patients with a high rate of previous cranioplasty failures. The bone regenerative effect may in particular have an impact on the long-term success rate of the implant.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kihlström Burenstam Linder L, Birgersson U, Lundgren K, et al. Patient-Specific Titanium-Reinforced Calcium Phosphate Implant for the Repair and Healing of Complex Cranial Defects. World Neurosurg. 2018. PMID: 30342265. doi:10.1016/j.wneu.2018.10.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。